SEC Filings

10-Q
AVEXIS, INC. filed this Form 10-Q on 11/09/2017
Entire Document
 

AveXis, Inc.

 

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

(In thousands, except share and per share data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended September 30, 

 

Nine Months Ended September 30, 

 

 

 

2017

    

2016

    

2017

    

2016

 

Revenue

 

$

 —

 

$

 —

 

$

 —

 

$

 —

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

 

16,095

 

 

7,083

 

 

38,898

 

 

17,325

 

Research and development

 

 

33,425

 

 

14,098

 

 

98,946

 

 

40,542

 

Total operating expenses

 

 

49,520

 

 

21,181

 

 

137,844

 

 

57,867

 

Loss from operations

 

 

(49,520)

 

 

(21,181)

 

 

(137,844)

 

 

(57,867)

 

Interest income

 

 

881

 

 

99

 

 

1,458

 

 

230

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss and comprehensive loss

 

$

(48,639)

 

$

(21,082)

 

$

(136,386)

 

$

(57,637)

 

Basic and diluted net loss per common share

 

$

(1.52)

 

$

(0.87)

 

$

(4.67)

 

$

(2.75)

 

Weighted-average basic and diluted common shares outstanding

 

 

31,941,185

 

 

24,166,113

 

 

29,228,847

 

 

20,958,421

 

 

The accompanying notes are an integral part of these consolidated financial statements.

4


 


© AveXis, Inc. All Rights Reserved.